Clover Health Investments (NASDAQ:CLOV) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Clover Health Investments (NASDAQ:CLOV) from a sell rating to a hold rating in a research report report published on Sunday morning.

CLOV has been the topic of several other reports. Canaccord Genuity Group reissued a “buy” rating and issued a $3.70 price target on shares of Clover Health Investments in a research note on Tuesday, January 20th. Zacks Research downgraded shares of Clover Health Investments from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Weiss Ratings reissued a “sell (d-)” rating on shares of Clover Health Investments in a research note on Monday, December 29th. Finally, Leerink Partners set a $3.00 price target on shares of Clover Health Investments and gave the company a “market perform” rating in a research note on Tuesday, October 21st. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Clover Health Investments presently has an average rating of “Hold” and an average price target of $3.23.

Clover Health Investments Stock Performance

NASDAQ CLOV opened at $2.04 on Friday. The firm’s fifty day moving average price is $2.43 and its two-hundred day moving average price is $2.66. The stock has a market cap of $1.05 billion, a PE ratio of -18.55 and a beta of 2.09. Clover Health Investments has a fifty-two week low of $2.01 and a fifty-two week high of $4.80.

Institutional Trading of Clover Health Investments

Institutional investors and hedge funds have recently modified their holdings of the business. Abel Hall LLC purchased a new position in shares of Clover Health Investments during the fourth quarter worth about $27,000. Clarity Wealth Advisors LLC bought a new stake in Clover Health Investments during the second quarter valued at approximately $28,000. Allworth Financial LP grew its stake in Clover Health Investments by 218.9% in the 3rd quarter. Allworth Financial LP now owns 9,509 shares of the company’s stock worth $29,000 after buying an additional 6,527 shares in the last quarter. Schonfeld Strategic Advisors LLC bought a new position in shares of Clover Health Investments in the 4th quarter worth $29,000. Finally, Alteri Wealth LLC purchased a new stake in shares of Clover Health Investments during the 2nd quarter valued at $30,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

About Clover Health Investments

Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.

At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.